-
Trends and Costs in Older Malignant Pleural Mesothelioma Patients
28 Jan 2026 19:07 GMT
… becomes evident that ongoing clinical trials are vital to explore … : malignant pleural mesothelioma, older adults, treatment patterns, clinical outcomes, healthcare … MPM management strategiesmalignant pleural mesothelioma trendsMPM costs and healthcare …
-
Therapeutic Frontiers in Malignant Mesothelioma Management
27 Jan 2026 11:09 GMT
… beyond traditional thresholds. Peritoneal mesothelioma shows particularly striking improvements, … care for unresectable pleural mesothelioma, replacing traditional chemotherapy regimens … promise in early-stage clinical trials.
Tumor Treating Fields (TTFields …
-
The Financial Impact of Chronic Illness: Mesothelioma as a Case Study
21 Jan 2026 14:45 GMT
… strain. Unlike more common illnesses, mesothelioma typically requires specialized care, long … limited to medical bills. Many mesothelioma patients experience significant income loss … seeking cutting-edge therapies or clinical trials.
Even Medicare, often a …
-
Your Guide to Improving Mesothelioma Quality of Life
13 Jan 2026 18:46 GMT
… American Society of Clinical Oncology (ASCO) .
Palliative care for mesothelioma can include … the European Journal of Clinical Nutrition found that mesothelioma patients are at … and clinical trials.
Get Help Improving Your Quality of Life With Mesothelioma
The …
-
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
08 Jan 2026 10:00 GMT
… Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and … important milestone for ODM-212 clinical development program and more importantly … encouraging Phase 1 results demonstrated clinical activity as monotherapy with manageable …
-
Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000–2024): A Cross-Sectional Study
06 Jan 2026 11:08 GMT
… to 1 drug; pleural mesothelioma has 2 indications corresponding … Gastric Cancer; MPM, Malignant Pleural Mesothelioma; EC, Esophageal Cancer; UC, … medicine and immunotherapy.
Clinical Trial Characteristics: Pivotal Clinical Trial Characteristics of Novel Multi …
-
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
12 Nov 2025 12:00 GMT
… clinical trial evaluating TT-4, Cyncado’s selective A2B receptor antagonist, in mesothelioma … investigator-initiated clinical trial of TT-4 in mesothelioma in Australia … and implementing the Australian trial; clinical trial outcomes and regulatory approvals; …
-
The Prospects of Palmitylethanolamide in Tumor Prevention and Treatment
30 Jan 2026 23:54 GMT
… may improve treatment outcomes.
Clinical Trial Design and Optimization
Necessity of … molecular mechanisms, optimization of clinical trial designs, improvement of drug … M, et al. Malignant mesothelioma-associated inflammatory microenvironment promotes tumor …
-
First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma
08 Sep 2025 23:57 GMT
… as ctDNA, with clinical outcomes.
Diffuse pleural mesothelioma is a rare, … .
“This is the first published clinical trial to show that perioperative combination … but potentially beneficial in resectable mesothelioma,” says Valsamo “Elsa” Anagnostou, M …
-
Pan-Cancer Analysis of WRN: From Multi-Omics Biomarker Discovery to Therapy-Guiding Functional Evidence
29 Jan 2026 12:42 GMT
… between WRN expression and tumorigenesis, clinical outcomes, and immunological characteristics across … therapeutic response to drugs entering clinical trials or approved by the FDA … large B-cell lymphoma; MESO, Mesothelioma; NB, Neuroblastoma; OV, Ovarian …